Products - Diabetes | Topic | NICE

Showing 9 products

Date | Sort by Title

Advice programme: Evidence summariesRemove ‘Advice programme: Evidence summaries’ filter

Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) (ESNM64)
Product type:
Advice
Programme:
Evidence summary
Published date:
2 December 2015
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM65)
Product type:
Advice
Programme:
Evidence summary
Published date:
2 December 2015
Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM62)
Product type:
Advice
Programme:
Evidence summary
Published date:
13 October 2015
Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)
Product type:
Advice
Programme:
Evidence summary
Published date:
3 July 2015
Type 2 diabetes: dulaglutide (ESNM59)
Product type:
Advice
Programme:
Evidence summary
Published date:
16 June 2015
Type 2 diabetes: alogliptin (ESNM20)
Product type:
Advice
Programme:
Evidence summary
Last updated:
1 October 2014
Published date:
21 May 2013
Type 2 diabetes: lixisenatide (ESNM26)
Product type:
Advice
Programme:
Evidence summary
Published date:
24 September 2013
Type 1 diabetes: insulin degludec (ESNM24)
Product type:
Advice
Programme:
Evidence summary
Published date:
10 September 2013
Type 2 diabetes: insulin degludec (ESNM25)
Product type:
Advice
Programme:
Evidence summary
Published date:
10 September 2013